Section 2: Methods (from DOI: 10.1016/j.adro.2020.04.015)
Revision as of 15:03, 24 June 2020 by Maintenance script (talk | contribs)
| Article | Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic (DOI: 10.1016/j.adro.2020.04.015) |
|---|---|
| Sections in this Publication | |
| Section | Section 1: Introduction (from DOI: 10.1016/j.adro.2020.04.015) |
| Section | Section 2: Methods (from DOI: 10.1016/j.adro.2020.04.015) |
| Section | Section 3: Results (from DOI: 10.1016/j.adro.2020.04.015) |
| Section | Section 4: Discussion (from DOI: 10.1016/j.adro.2020.04.015) |
| Section | References (from DOI: 10.1016/j.adro.2020.04.015) |
| Named Entities in this Section | |
| Entity | Human (species) |
| Dataset | Pubtator Central BioC-JSON formatted article files |
From publication: "Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic" published as Adv Radiat Oncol; 2020 May 05. DOI: https://doi.org/10.1016/j.adro.2020.04.015
Section 3: Methods
Section 1:Methods:
Medical records of consecutive patients who presented with symptoms of RP in March 2020 were reviewed. The first regional COVID-19 case was diagnosed on 3/1/2020. All patients underwent COVID-19 qualitative RNA testing. Patient imaging and clinical course data were reviewed as were COVID-19 testing results. This study was completed under an institutional review board approved protocol.
